A screenshot of a document titled "Study Topic: EXALGO Use in the Clinical Setting". The document is divided into two sections. The top section has a white background with a pattern of small black dots. Below the pattern there is a blue header with the text "Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain". The bottom section has the Exalgo logo in blue and white. The text is written in black font and is centered on the page.
Description 
Type
Category
Source 1 of 20
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2011
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2011
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2010
Collection
-
Date
2009
Collection
-
Date
2010
Collection
-
Date
2010
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
![A bar graph that shows the results of a study about EXALGO. The graph is divided into three sections.<br /><br />The first section is titled "Studies show switching to EXALGO could provide long lasting analgesia" and shows that in its 12-week pivotal trial EXALGO reduced pain intensity at study endpoint and throughout the trial. The second section is labeled "Conversion/Treatment Phase" and has a blue arrow pointing to the left side of the graph. The third section is labeled "6.4 Week 1 [etc.]"](https://oida-resources-images.azureedge.net/public/full/20a0a652-bcb7-4362-871c-1be2d99a256b.jpeg)
